FILORGA was founded in 1978 by Michel Tordjman, a French doctor of aesthetic medicine, with a fascination for cellular biology. Michel Tordjman pioneered NCTF® , New Cellular Treatment Factor, a unique injectable solution that prevents, slows and corrects the effects of skin ageing.
The Medi-Cosmetic Revolution
In 2007, France’s scientific research authority (CNRS) discovered a way of enabling active ingredient like NCTF® to be absorbed into the dermis without injection treatment. Driven by its CEO, Didier Tabary, FILORGA was able to make its anti-ageing expertise available to the general public: the result was MEDI-COSMETIQUE®, a range of products based on medical quality NCTF® and hyaluronic acid.